Remove journals pharmaceutical-technology pharmaceutical-technology-july-2022
article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Cited 25 September 2022].

article thumbnail

PM360 Now Accepting Entries for 2022 Pharma Choice Awards

PM360

PM360 Now Accepting Entries for 2022 Pharma Choice Awards. NEW YORK, NY, July 27, 2022 : The 2022 PM360 Pharma Choice Awards are officially open for entries. The complete 2022 PM360 Pharma Choice nomination criteria and online entry form is available at www.pm360online.com/pharmachoice. Contact: Kayla Walsh.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

12 New Ways Companies Are Helping to Improve Adherence

PM360

Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. Feb-May 2022. That’s why it uses technological innovation to empower pharmacists to provide direct consultative care and boost medication adherence.

article thumbnail

Possible cause for Paxlovid rebound uncovered

Pharmaceutical Technology

However, a recent study in the Journal of American Medical Association suggests that Paxlovid may not be the sole cause for this relapse in Covid-19 symptoms. In late July, the US government placed an order for 105 million doses of Pfizer’s Covid-19 vaccine as part of a $3.2 Paxlovid rebound study. billion dollar contract.